ArticleTheoretical medicine and bioethics2020

The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.

Timothy Daly et al.PubMed ↗Publisher ↗

No numbers read from the abstract.